project . 2016 - 2021 . On going

AMYPAD

Amyloid imaging to Prevent Alzheimer’s Disease – Sofia ref.: 115952
Open Access mandate for Publications European Commission
  • Funder: European CommissionProject code: 115952 Call for proposal: H2020-JTI-IMI2-2015-05-two-stage
  • Funded under: H2020 | IMI2-RIA Overall Budget: 27,329,300 EURFunder Contribution: 11,999,900 EUR
  • Status: On going
  • Start Date
    01 Oct 2016
    End Date
    30 Sep 2021
  • Detailed project information (CORDIS)
  • Open Access mandate
    Research Data: No
Description
Beta-amyloid (β-amyloid) deposition is considered to be a necessary - but not sufficient - step on the path towards Alzheimer’s disease (AD). Depiction of brain β-amyloid in vivo can support an early diagnosis, and even provide an opportunity for consider secondary prevention of AD. Currently, however, the value of β-amyloid PET remains elusive, reason why this procedure is typically not reimbursed. Understanding the value of imaging of β-amyloid using positron emission tomography (PET) provides a unique opportunity to achieve 3 major goals: 1) improve the diagnostic workup of patients suspected of AD and their management; 2) stratify risk for AD and select homo...
Description
Beta-amyloid (β-amyloid) deposition is considered to be a necessary - but not sufficient - step on the path towards Alzheimer’s disease (AD). Depiction of brain β-amyloid in vivo can support an early diagnosis, and even provide an opportunity for consider secondary prevention of AD. Currently, however, the value of β-amyloid PET remains elusive, reason why this procedure is typically not reimbursed. Understanding the value of imaging of β-amyloid using positron emission tomography (PET) provides a unique opportunity to achieve 3 major goals: 1) improve the diagnostic workup of patients suspected of AD and their management; 2) stratify risk for AD and select homo...
Powered by OpenAIRE Research Graph
Any information missing or wrong?Report an Issue